The clinical trial assessment of infrastructure matrix tool (CT AIM) to improve the quality of research conduct in the community
| Autor: | Lucy Gansauer, Kathleen Igo, Robin Zon, James D. Bearden, Angela Carrigan, Octavio Quiñones, Kandie Dempsey, Eileen Dimond, Donna M. Bryant, Andrea Denicoff, Worta McCaskill-Stevens, Kathy Wilkinson, Maria C. Bell, Stephen S. Grubbs, Diane St. Germain, Marjorie J. Good, Mitchell Berger, Maria Gonzalez, Beth LaVasseur, Phil Stella |
|---|---|
| Rok vydání: | 2014 |
| Předmět: | |
| Zdroj: | Journal of Clinical Oncology. 32:6512-6512 |
| ISSN: | 1527-7755 0732-183X |
| DOI: | 10.1200/jco.2014.32.15_suppl.6512 |
| Popis: | 6512 Background: ASCO described minimum standards and exemplary attributes for CT sites to improve research quality (Zon et al JCO 2008, JOP 2011; Baer et al JOP 2010). Based on these attributes, the NCI Community Cancer Centers Program (NCCCP) developed and piloted the CT AIM Tool to facilitate research program improvements through self-assessment and benchmarking. The tool identified 9 attributes (see Table) each with 3 progressive levels for research sites to “score” their program from less (Level 1) to more (Level 3) exemplary CT infrastructure (e.g. Level 1- only phase 3 treatment trials open vs. Level 3 – Phase 1/2/3, cancer control and prevention trials open). Methods: From 2011-13, 21 NCCCP sites self assessed their CT programs annually using the tool. Results: See Table. Conclusions: Statistically significant increases (p < 0.0001) occurred in Level 3 (more exemplary) infrastructure ratings from 2011 to 2013 across all 9 attribute categories assessed at the 21 sites. Statistically significant gai... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|